Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation
Stopped early
Conditions studied: Liver Transplantation
In brief
The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.
Key facts
- Study ID
- NCT01299441
- Run by
- Mayo Clinic
- People needed
- 40
- Starts
- 2011-02-01
- Expected to finish
- 2016-10-01
- Last updated by the study team
- 2017-03-24
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing liver transplantation surgery
You may not qualify if…
- Patients who are anticipated to remain intubated postoperatively for greater than 24 hours.
Where it is running
- Mayo Clinic — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.